Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics

Cancer Genetics

Volumn 204, Issue 7, 2011, Pages 366-374

  Drieschner, Norbert ^a   Rippe, Volkhard ^a   Laabs, Anne ^a   Dittberner, Lea ^a   Nimzyk, Rolf ^a   Junker, Klaus ^b   Rommel, Birgit ^a   Kiefer, Yvonne ^a   Belge, Gazanfer ^a   Bullerdiek, Jörn ^a,c   Sendt, Wolfgang ^d  

^a UNIVERSITY OF BREMEN   (Germany)

^b Hospital Bremen Mitte   (Germany)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^d Department of General and Visceral Surgery of the St Joseph Stift ^*  (Germany)

Author keywords

Benign thyroid lesions; Conventional cytogenetic; Cytogenetic subgroups; Interphase FISH; Thyroid

Indexed keywords

ARTICLE; CHROMOSOME 19Q; CHROMOSOME 2P; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; CONVENTIONAL CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; INTERPHASE FLUORESCENCE IN SITU HYBRIDIZATION; KARYOTYPE 46,XX; KARYOTYPE 46,XY; MAJOR CLINICAL STUDY; MOLECULAR PROBE; NODULAR GOITER; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STRUCTURAL CHROMOSOME ABERRATION; THYROID ADENOMA; THYROID TUMOR; TRISOMY 7; CHROMOSOME 19; CHROMOSOME 21; CHROMOSOME 7; COMPARATIVE STUDY; CYTOGENETICS; GENETICS; INTERPHASE; KARYOTYPING; METHODOLOGY; TRISOMY;

CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 7; CYTOGENETICS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; KARYOTYPING; THYROID NEOPLASMS; TRISOMY;

EID: 80054815332     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2011.03.008     Document Type: Article

References (28)

1. Roque L., Castedo S., Gomes P., Soares P., Clode A., Soares J. Cytogenetic findings in 18 follicular thyroid adenomas. Cancer Genet Cytogenet 1993, 67:1-6.
2. Sozzi G., Miozzo M., Cariani T.C., Bongarzone I., Pilotti S., Pierotti M.A., Della Porta G. A t(2;3)(q12-13;p24-25) in follicular thyroid adenomas. Cancer Genet Cytogenet 1992, 64:38-41.
3. Antonini P., Venuat A.M., Linares G., Caillou B., Schlumberger M., Travagli J.P., Berger R., Parmentier C. Cytogenetic abnormalities in thyroid adenomas. Cancer Genet Cytogenet 1991, 52:157-164.
4. Belge G., Thode B., Bullerdiek J., Bartnitzke S. Aberrations of chromosome 19. Do they characterize a subtype of benign thyroid adenomas?. Cancer Genet Cytogenet 1992, 60:23-26.
5. Bol S., Belge G., Rippe V., Bullerdiek J. Molecular cytogenetic investigations define a subgroup of thyroid adenomas with 2p21 breakpoints clustered to a region of less than 450 kb. Cytogenet Cell Genet 2001, 95:189-191.
6. Bondeson L., Bengtsson A., Bondeson A.G., Dahlenfors R., Grimelius L., Wedell B., Mark J. Chromosome studies in thyroid neoplasia. Cancer 1989, 64:680-685.
7. Roque L., Clode A., Belge G., Pinto A., Bartnitzke S., Santos J.R., Thode B., Bullerdiek J., Castedo S., Soares J. Follicular thyroid carcinoma: chromosome analysis of 19 cases. Genes Chromosomes Cancer 1998, 21:250-255.
8. van den Berg E., Oosterhuis J.W., de Jong B., Buist J., Vos A., Dam A., Vermeij B. Cytogenetics of thyroid follicular adenomas. Cancer Genet Cytogenet 1990, 44:217-222.
9. Belge G., Thode B., Rippe V., Bartnitzke S., Bullerdiek J. A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors. Hum Genet 1994, 94:198-202.
10. Belge G., Roque L., Soares J., Bruckmann S., Thode B., Fonseca E., Clode A., Bartnitzke S., Castedo S., Bullerdiek J. Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology. Cancer Genet Cytogenet 1998, 101:42-48.
11. Bol S., Belge G., Thode B., Bartnitzke S., Bullerdiek J. Structural abnormalities of chromosome 2 in benign thyroid tumors. Three new cases and review of the literature. Cancer Genet Cytogenet 1999, 114:75-77.
12. Werner M., Wilkens L., Aubele M., Nolte M., Zitzelsberger H., Komminoth P. Interphase cytogenetics in pathology: principles, methods, and applications of fluorescence in situ hybridization (FISH). Histochem Cell Biol 1997, 108:381-390.
13. Wolfe K.Q., Herrington C.S. Interphase cytogenetics and pathology: a tool for diagnosis and research. J Pathol 1997, 181:359-361.
14. Barril N., Carvalho-Sales A.B., Tajara E.H. Detection of numerical chromosome anomalies in interphase cells of benign and malignant thyroid lesions using fluorescence in situ hybridization. Cancer Genet Cytogenet 2000, 117:50-56.
15. Criado B., Barros A., Suijkerbuijk R.F., Weghuis D.O., Seruca R., Fonseca E., Castedo S. Detection of numerical alterations for chromosomes 7 and 12 in benign thyroid lesions by in situ hybridization. Histological implications. Am J Pathol 1995, 147:136-144.
16. Roque L., Serpa A., Clode A., Castedo S., Soares J. Significance of trisomy 7 and 12 in thyroid lesions with follicular differentiation: a cytogenetic and in situ hybridization study. Lab Invest 1999, 79:369-378.
17. Taruscio D., Carcangiu M.L., Ried T., Ward D.C. Numerical chromosomal aberrations in thyroid tumors detected by double fluorescence in situ hybridization. Genes Chromosomes Cancer 1994, 9:180-185.
18. Chen F., Clark D.P., Hawkins A.L., Morsberger L.A., Griffin C.A. A break-apart fluorescence in situ hybridization assay for detecting RET translocations in papillary thyroid carcinoma. Cancer Genet Cytogenet 2007, 178:128-134.
19. Cinti R., Yin L., Ilc K., Berger N., Basolo F., Cuccato S., Giannini R., Torre G., Miccoli P., Amati P., Romeo G., Corvi R. RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH. Cytogenet Cell Genet 2000, 88:56-61.
20. Dwight T., Thoppe S.R., Foukakis T., Lui W.O., Wallin G., Hoog A., Frisk T., Larsson C., Zedenius J. Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors. J Clin Endocrinol Metab 2003, 88:4440-4445.
21. Xiao S., Renshaw A., Cibas E.S., Hudson T.J., Fletcher J.A. Novel fluorescence in situ hybridization approaches in solid tumors. Characterization of frozen specimens, touch preparations, and cytological preparations. Am J Pathol 1995, 147:896-904.
22. Bullerdiek J., Boschen C., Bartnitzke S. Aberrations of chromosome 8 in mixed salivary gland tumors-cytogenetic findings on seven cases. Cancer Genet Cytogenet 1987, 24:205-212.
23. Castagne C., Muhlematter D., Beyer V., Parlier V., van Melle G., Jotterand M. Determination of cutoff values to detect small aneuploid clones by interphase fluorescence in situ hybridization: the Poisson model is a more appropriate approach. Should single-cell trisomy 8 be considered a clonal defect?. Cancer Genet Cytogenet 2003, 147:99-109.
24. Belge G., Rippe V., Meiboom M., Drieschner N., Garcia E., Bullerdiek J. Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations. Cytogenet Cell Genet 2001, 93:48-51.
25. Rippe V., Drieschner N., Meiboom M., Escobar H.M., Bonk U., Belge G., Bullerdiek J. Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas. Oncogene 2003, 22:6111-6114.
26. Rippe V., Dittberner L., Lorenz V.N., Drieschner N., Nimzyk R., Sendt W., Junker K., Belge G., Bullerdiek J. The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas. PLoS ONE 2010, 5:e9485.
27. Meiboom M., Belge G., Bol S., El-Aouni C., Schoenmakers E.F., Bullerdiek J. Does conventional cytogenetics detect the real frequency of 19q13 aberrations in benign thyroid lesions? A survey of 38 cases. Cancer Genet Cytogenet 2003, 146:70-72.
28. Studer H., Derwahl M. Mechanisms of nonneoplastic endocrine hyperplasia-a changing concept: a review focused on the thyroid gland. Endocr Rev 1995, 16:411-426.